Meet Corealis Pharma at PBSS
Join the conversation around preclinical development, IND-enabling strategy, and regulatory readiness.
Corealis Pharma is attending PBSS: Small Molecule Preclinical Development and IND Filing: Nuts, Bolts, Best Practices, and Regulatory Strategies on April 17th. The workshop focuses on the preclinical studies required for small molecule IND filings, regulatory strategy, and approaches to avoiding clinical holds.
Attending PBSS on IND filing strategy?
Connect with Annie Staten to discuss your development goals and how Corealis can support your program.
Meet Us There
Stop by to connect with our team and discover how Corealis turns complex molecules into clinical success stories.
